Albumin-micelles via a one-pot technology platform for the delivery of drugs†
Abstract
A new micelle delivery platform based on albumin coated nanoparticles is able to selectively deliver the payload to cancerous cells while healthy cells remain less affected. The technology is simple and can be used in a one-pot procedure.